Mofilet-S 360 30 Tablets

Babies: Not applicable. Lactating mothers: It is unsafe to use this medicine during breastfeeding. Studies have shown that the drug passes into the breastmilk and causes harm to the baby. Pregnancy: It is unsafe to use this medicine during pregnancy.
Studies have shown that the medicine causes harmful effects on the developing baby. Seek a doctor's advice before taking this medicine. Alcohol: It is safe to consume alcohol while taking this medicine. Driving: This medicine does not affect your ability to drive. Kidney: It is safe to use this medicine in patients with kidney disease.
Dose adjustment is not required. Seek a doctor's advice before taking this medicine. Liver: Please consult your doctor before using this medicine.
Limited information is available on the use of this medicine in patients with liver disease..

Nausea Headache Abdominal pain Diarrhea Vomiting High blood pressure Decreased white blood cell count.

Mofilet belongs to the class of immunosuppressants used in the prevention of organ rejection in transplant patients. It helps the body to accept the new organ and works by reducing the action of the body's defence system..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Take this medicine as prescribed by your doctor. • To get better results to take this medicine at a fixed time regularly. • Finish the entire course of this medicine. • Do not stop taking this medicine too early without consulting your doctor. • If you experience sore throat, fever, and mouth ulcers while taking this medicine, inform your doctor..

Major • Mofilet + Adalimumab: Concurrent use of these medicines lead to an increase in the risk of life-threatening infections • Mofilet + Baricitinib: Concurrent use of these medicines lead to an increase in the risk of life-threatening infections • Mofilet + Deferiprone: Concurrent use of these medicines lead to a decrease in the white blood cell count • Mofilet + Etanercept: Concurrent use of these medicines lead to an increase in the risk of life-threatening infections • Mofilet + Leflunomide: Concurrent use of these medicines lead to an increase in the risk of life-threatening infections Moderate • Mofilet + Azathioprine: Concurrent use of these medicines lead to an increase in the risk of bleeding, muscle pain, and fever • Mofilet + Bacitracin: Concurrent use of these medicines lead to a decrease in the therapeutic effect of mofilet • Mofilet + Cefazolin: Concurrent use of these medicines lead to a decrease in the therapeutic effect of mofilet • Mofilet + Cefoperazone: Concurrent use of these medicines lead to a decrease in the therapeutic effect of mofilet • Mofilet + Amoxicillin: Concurrent use of these medicines lead to a decrease in the therapeutic effect of mofilet.